文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

机构信息

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.


DOI:10.1093/cid/ciaa1249
PMID:33029620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7499497/
Abstract

Defining the duration of infectivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has major implications for public health and infection control practice in healthcare facilities. Early in the pandemic, most hospitals required 2 negative RT-PCR tests before discontinuing isolation in patients with Covid-19. Many patients, however, have persistently positive RT-PCR tests for weeks to months following clinical recovery, and multiple studies now indicate that these generally do not reflect replication-competent virus. SARS-CoV-2 appears to be most contagious around the time of symptom onset, and infectivity rapidly decreases thereafter to near-zero after about 10 days in mild-moderately ill patients and 15 days in severely-critically ill and immunocompromised patients. The longest interval associated with replication-competent virus thus far is 20 days from symptom onset. This review summarizes evidence-to-date on the duration of infectivity of SARS-CoV-2, and how this has informed evolving public health recommendations on when it is safe to discontinue isolation precautions.

摘要

确定严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的传染性持续时间对医疗机构中的公共卫生和感染控制实践具有重大意义。在大流行早期,大多数医院要求患有 Covid-19 的患者在停止隔离之前进行 2 次阴性 RT-PCR 检测。然而,许多患者在临床康复后数周到数月内持续进行 RT-PCR 检测呈阳性,多项研究表明这些通常不反映具有复制能力的病毒。SARS-CoV-2 似乎在症状出现时最具传染性,此后传染性迅速下降,大约在轻度至中度疾病患者中 10 天后和严重至危重病患者和免疫功能低下患者中 15 天后接近零。迄今为止与具有复制能力的病毒相关的最长间隔时间是从症状出现开始的 20 天。这篇综述总结了迄今为止关于 SARS-CoV-2 传染性持续时间的证据,以及这些证据如何为不断发展的关于何时安全停止隔离预防措施的公共卫生建议提供信息。

相似文献

[1]
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Clin Infect Dis. 2021-4-26

[2]
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.

Virol J. 2021-4-7

[3]
SARS-CoV-2: The viral shedding vs infectivity dilemma.

Infect Dis Health. 2020-8

[4]
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.

Clin Infect Dis. 2020-12-17

[5]
Coronaviruses - a new old menace.

Postepy Biochem. 2020-12-31

[6]
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019.

Clin Infect Dis. 2021-11-2

[7]
Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus.

J Clin Microbiol. 2021-10-19

[8]
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.

Endocrine. 2020-9-1

[9]
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].

Mikrobiyol Bul. 2020-7

[10]
Dynamics of viral RNA load, virus culture, seroconversion & infectivity in COVID-19 patients: Implications on isolation policy.

Indian J Med Res.

引用本文的文献

[1]
Cognitively-plausible reinforcement learning in epidemiological agent-based simulations.

Front Epidemiol. 2025-7-28

[2]
Reagent efficiency and analytical sensitivity optimization for a reliable SARS-CoV-2 pool-based testing strategy.

Heliyon. 2025-1-2

[3]
Deisolation in the Healthcare Setting Following Recent COVID-19 Infection.

Viruses. 2024-7-15

[4]
Completion rates and myelosuppression degrees of cancer patients receiving radiotherapy or chemoradiotherapy unchanged regardless of delay duration after Omicron infection.

Sci Rep. 2024-6-20

[5]
Pathophysiological, immunological, and inflammatory features of long COVID.

Front Immunol. 2024

[6]
Transmission risk of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis.

Infect Med (Beijing). 2023-3

[7]
The efficacy of hydrogen/oxygen therapy favored the recovery of omicron SARS-CoV-2 variant infection: results of a multicenter, randomized, controlled trial.

J Clin Biochem Nutr. 2023-11

[8]
Predictions from standard epidemiological models of consequences of segregating and isolating vulnerable people into care facilities.

PLoS One. 2023

[9]
ANCOC Score to Predict Mortality in Different SARS-CoV-2 Variants and Vaccination Status.

J Clin Med. 2023-9-8

[10]
Impact and management of COVID-19 in liver transplant candidates and recipients.

Ann Gastroenterol. 2023

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索